ICOS Corporation, headquartered in the United States, is a prominent player in the biotechnology industry, specialising in the development of innovative solutions for the healthcare sector. Founded in 1990, the company has achieved significant milestones, including advancements in drug discovery and development, particularly in the fields of oncology and metabolic diseases. ICOS is renowned for its core products, which include cutting-edge therapeutics and diagnostic tools that leverage proprietary technologies. These offerings are distinguished by their precision and efficacy, setting ICOS apart in a competitive market. With a strong presence in North America and Europe, ICOS Corporation has established itself as a leader in biopharmaceutical innovation, consistently recognised for its contributions to improving patient outcomes and advancing medical science.
We don't have data for ICOS Corporation, but we can show you information about their parent organization instead.
View parent company